Atlas Trials

Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy

Clinical trial NCT06891521 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06891521
Sponsor
Qinghai Red Cross Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
CancerAdverse Events
Start date
2025-03-20
Primary completion
2027-03-01
Enrollment
123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.